HIV-1 RNA levels, resistance, and drug diffusion in semen versus blood in patients receiving a lopinavir-containing regimen [1]

Journal of Acquired Immune Deficiency Syndromes

Volumn 32, Issue 4, 2003, Pages 462-464

  Lafeuillade, A ^a   Solas, C ^b   Chadapaud, S ^a   Hittinger, G ^a   Poggi, C ^c   Lacarelle, B ^b  

^a Hopital Chalucet Toulon   (France)

^b TIMONE HOSPITAL   (France)

^c GENERAL HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; VIRUS RNA;

ADULT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DIFFUSION; DRUG PENETRATION; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MALE; MONONUCLEAR CELL; PLASMA; PRIORITY JOURNAL; SEMINAL PLASMA; VIREMIA; VIRUS LOAD;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; GENOTYPE; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; MALE; MUTATION; PYRIMIDINONES; RITONAVIR; RNA, VIRAL; SEMEN; TISSUE DISTRIBUTION;

EID: 0037377825     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200304010-00018     Document Type: Letter

References (9)

1. Gupta P, Mellors J, Kingsley L, et al. High viral load in semen of human immunodeficiency virus type-1-infected men at all stages of disease and its reduction by therapy with protease and non-nucleoside reverse transcriptase inhibitors. J Virol. 1997;71:6271-6275.
2. Vernazza PL, Gilliam BL, Flepp M, et al. Effect of antiviral treatment on the shedding of HIV-1 in semen. AIDS. 1997;11:1249-1254.
3. Ball JK, Rowe T, Curran R, et al. Poor reduction of HIV-1 RNA titres in nucleoside reverse transcriptase inhibitor experienced patients treated with indinavir combination therapy. Sex Transm Infect. 1999;75:337-339.
4. Lafeuillade A, Solas C, Halfon P, et al. Differences in the detection of three HIV-1 protease inhibitors in non-blood compartments: clinical correlations. HIV Clin Trials. 2002;3:27-35.
5. Taylor S, Back DJ, Drake SM, et al. Antiretroviral drug concentrations in semen of HIV-infected men: differential penetration of indinavir, ritonavir and saquinavir. J Antimicrob Chemother. 2002; 48:351-354.
6. Tachet A, Dulioust E, salmon D et al. Detection and quantification of HIV-1 in semen: identification of a subpopulation of men at high potential risk of viral sexual transmission. AIDS. 1999;13: 823-831.
7. Kempf DJ. Isaacson JD, King MS, et al. Identification of genotypic changes in human immunodeficiency virus protease that correlate with reduced susceptibility to the protease inhibitor lopinavir among viral isolates from protease inhibitor-experienced patients. J Virol. 2001;75:7462-7469.
8. Sankatsing SUC. Droste J, Burger D, et al. Limited penetration of lopinavir into seminal plasma of HIV-1-infected men. AIDS. 2002; 16:1698-1699.
9. Launay O. Tod M, Louchahi K, et al. Differential diffusion of Indinavir (IDV) and Lopinavir (LPV) in genital secretions of HIV-infected women. Program and Abstracts from the 42th Interscience Conference on Antimicrob Agents Chemother [abstract H-1712]. San Diego, CA, September 27-30, 2002.